Overall, we determined that LINC00665 acted as an oncogene by modulating miR-126-5p, thereby aggravating tumorigenesis, demonstrating that LINC00665 might be a valuable and promising therapeutic target for CRC. This evidence concerns the gene LINC00665 and colorectal carcinoma.